Concepedia

Publication | Closed Access

Clinical trial of valproic acid and all‐trans retinoic acid in patients with poor‐risk acute myeloid leukemia

185

Citations

20

References

2005

Year

Abstract

Treatment with VPA/ATRA results in transient disease control in a subset of patients with AML that has evolved from a myeloproliferative disorder but not in patients with a primary or MDS-related AML.

References

YearCitations

Page 1